Chronic Myelomonocytic Leukemia

Common Name(s)

Chronic Myelomonocytic Leukemia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Myelomonocytic Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Myelomonocytic Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Chronic Myelomonocytic Leukemia" returned 142 free, full-text research articles on human participants. First 3 results:

Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review.
 

Author(s): Eric Grignano, Arsene Mekinian, Thorsten Braun, Eric Liozon, Mohamed Hamidou, Olivier Decaux, Xavier Puéchal, Jean Emmanuel Kahn, Yoland Schoindre, Julien Rossignol, Olivier Lortholary, Bertrand Lioger, Olivier Hermine, Sophie Park, Lionel Ades, François Montestruc, Laure Ricard, Claude Gardin, Pierre Fenaux, Olivier Fain,

Journal: Leuk. Res.. 2016 Aug;47():136-41.

 

We wanted to describe the characteristics, treatment and outcome of autoimmune and inflammatory diseases (SAIDs) associated with chronic myelomonocytic leukemia (CMML), and conducted a French multicenter retrospective study and a literature review. We included 26 cases of CMML (median ...

Last Updated: 26 Jul 2016

Go To URL
Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
 

Author(s): Jean-Baptiste Fraison, Arsène Mekinian, Eric Grignano, Jean-Emmanuel Kahn, Jean-Benoit Arlet, Olivier Decaux, Guillaume Denis, Anne-Laure Buchdahl, Mohamed Omouri, Gwenola Maigne, Achille Aouba, Nathalie Leon, Sabine Berthier, Eric Liozon, Sophie Park, Claude Gardin, Olivier Lortholary, Julien Rossignol, Pierre Fenaux, Olivier Fain, Thorsten Braun

Journal: Leuk. Res.. 2016 Apr;43():13-7.

 

This retrospective study describes efficacy of Azacitidine on autoimmune disorders (AID) associated with MDS/CMML in 22 patients. Response of AID to Azacitidine was observed in 19 patients (86%). Reduction or discontinuation of steroids and/or immunosuppressive therapy (IST) was possible ...

Last Updated: 23 Mar 2016

Go To URL
Transformation from atypical chronic myeloid leukemia to chronic myelomonocytic leukemia as progression of myeloid neoplasm with platelet-derived growth factor ß rearrangement.
 

Author(s): Xue Shi, Zhan Su, Chunting Zhao, Xianqi Feng

Journal: J Cancer Res Ther. ;11(4):914-6.

 

Myeloid neoplasms associated with platelet-derived growth factor b (PDGFRB) rearrangement usually keep only one morphologic type unless blast crisis. We describe a unique case of hematological features transformation from atypical chronic myeloid leukemia to chronic myelomonocytic ...

Last Updated: 17 Feb 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Chronic Myelomonocytic Leukemia" returned 11 free, full-text review articles on human participants. First 3 results:

Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management.
 

Author(s): Mrinal M Patnaik, Ayalew Tefferi

Journal: Am. J. Hematol.. 2016 Jun;91(6):631-42.

 

Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder characterized by overlapping features of myelodysplastic syndromes and myeloproliferative neoplasms. Diagnosis is based on the presence of persistent (>3 months) peripheral blood monocytosis (>1 × 10(9) ...

Last Updated: 17 May 2016

Go To URL
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia.
 

Author(s): M M Patnaik, A Tefferi

Journal:

 

Chronic myelomonocytic leukemia (CMML) is a clonal stem cell disorder associated with peripheral blood monocytosis and an inherent tendency to transform to acute myeloid leukemia. CMML has overlapping features of myelodysplastic syndromes and myeloproliferative neoplasms. Clonal cytogenetic ...

Last Updated: 6 Feb 2016

Go To URL
Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemia.
 

Author(s): Natasha Kekre, Vincent T Ho

Journal: Am. J. Hematol.. 2016 Jan;91(1):123-30.

 

The efficacy of hematopoietic stem cell transplantation (HSCT) is not well established in Philadelphia chromosome negative myeloproliferative neoplasms (Ph- MPNs). Without randomized prospective trials comparing HSCT to non-HSCT options or comparing HSCT regimens, physicians must ...

Last Updated: 15 Jan 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia
 

Status: Recruiting

Condition Summary: Chronic Myelomonocytic Leukemia

 

Last Updated: 26 Aug 2016

Go to URL
Study of Lenzilumab (KB003) in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)
 

Status: Recruiting

Condition Summary: Chronic Myelomonocytic Leukemia (CMML)

 

Last Updated: 13 Mar 2017

Go to URL
Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia
 

Status: Recruiting

Condition Summary: Leukemia, Myelomonocytic, Chronic

 

Last Updated: 3 Jul 2017

Go to URL